StockData
ELI LILLY & Co logo

ELI LILLY & Co

LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3026% above fair value
$1410.99−6.55 (-0.46%)

Close on Nov 2, 2026Market cap $1.33TP/E 45.8Yield 0.44%

Eli Lilly Non-major products combined by Quarter

Non-major products combined — Worldwide revenue growth YoY (%) [Q1–Q3 10-Q & FY 10-K] (%)

QuarterlyAnnual

Eli Lilly Non-major products combined: 16.0% in Q2 2026, up 19.0 pts from a year earlier.

Latest, Q2 2026
16.0%
Period ended Jun 30, 2026
Change on a year earlier
+19.0 pts
-3.0% in Q2 2025
History
26 quarters
Since Q1 2018
Sources
26
Documents cited below

Where the Q2 2026 figure comes from

“|| Other | 1,842 | 1,481 | 3,322 | 2,859 | 16”

Source: Form 10-Q FY2026Q2 (filed 2026-08-05) ↗

Reported in Form 10-Q / 10-K MD&A.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedNon-major products combined — Worldwide revenue growth YoY (%) [Q1–Q3 10-Q & FY 10-K] (%)Year on yearSource
Q2 2026Jun 30, 202616.0%+19.0 ptsForm 10-Q FY2026Q2 (filed 2026-08-05) ↗
Q1 2026Mar 31, 202614.0%-182.2 ptsForm 10-Q FY2026Q1 (filed 2026-04-30) ↗
Q3 2025Sep 30, 20256.0%-23.0 ptsForm 10-Q FY2025Q3 (filed 2025-10-30) ↗
Q2 2025Jun 30, 2025-3.0%-5.0 ptsForm 10-Q FY2025Q2 (filed 2025-08-07) ↗
Q1 2025Mar 31, 2025196.2%+195.2 ptsForm 10-Q FY2025Q1 (filed 2025-05-01) ↗
Q3 2024Sep 30, 202429.0%+12.0 ptsForm 10-Q FY2024Q3 (filed 2024-10-30) ↗
Q2 2024Jun 30, 20242.0%-6.0 ptsForm 10-Q FY2024Q2 (filed 2024-08-08) ↗
Q1 2024Mar 31, 20241.0%+12.0 ptsForm 10-Q FY2024Q1 (filed 2024-04-30) ↗
Q3 2023Sep 30, 202317.0%+26.0 ptsForm 10-Q FY2023Q3 (filed 2023-11-02) ↗
Q2 2023Jun 30, 20238.0%-3.0 ptsForm 10-Q FY2023Q2 (filed 2023-08-08) ↗
Q1 2023Mar 31, 2023-11.0%-9.0 ptsForm 10-Q FY2023Q1 (filed 2023-04-27) ↗
Q3 2022Sep 30, 2022-9.0%-24.0 ptsForm 10-Q FY2022Q3 (filed 2022-11-01) ↗
Q2 2022Jun 30, 202211.0%+4.0 ptsForm 10-Q FY2022Q2 (filed 2022-08-04) ↗
Q1 2022Mar 31, 2022-2.0%0.0 ptsForm 10-Q FY2022Q1 (filed 2022-04-29) ↗
Q3 2021Sep 30, 202115.0%+32.0 ptsForm 10-Q FY2021Q3 (filed 2021-10-27) ↗
Q2 2021Jun 30, 20217.0%+33.0 ptsForm 10-Q FY2021Q2 (filed 2021-08-03) ↗

Cite this data

StockData. (2026). Eli Lilly Non-major products combined (%), quarterly Q1 2018–Q2 2026 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/med-other-products-yoy

See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.